Low Intensity Focused Ultrasound for Parkinson's Disease

Sponsor
Ali Rezai
Study ID
NCT06763692
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
45 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • LIFU Neuromodulation — DEVICE
    Subjects will undergo a single LIFU of the target brain region

Study Details

This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with parkinson's Disease

Key Dates

First listed
Jan 8, 2025
Start date
Dec 1, 2026
Status verified
Feb 2026
Primary completion
Mar 30, 2027
Completion
Mar 30, 2028

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: LIFU Neuromodulation

Primary Outcome Measure

Occurrence of Treatment Emergent Adverse Events [ Time Frame: baseline and day 7, 30 and 90 after study procedure ]

Find similar trials

Nationwide
Parkinson's disease trialsNeurology trialsBrain disorders trials

Related Studies